S&P 500   3,934.38 (-0.73%)
DOW   33,476.46 (-0.90%)
QQQ   282.04 (-0.64%)
AAPL   142.16 (-0.34%)
MSFT   245.42 (-0.80%)
META   115.90 (+0.49%)
GOOGL   92.83 (-0.94%)
AMZN   89.09 (-1.39%)
TSLA   179.05 (+3.23%)
NVDA   170.01 (-0.98%)
NIO   12.63 (-5.82%)
BABA   91.34 (-3.01%)
AMD   68.59 (-2.67%)
T   19.09 (-0.16%)
MU   54.87 (-0.60%)
CGC   2.87 (-7.12%)
F   13.18 (+0.46%)
GE   81.45 (-2.61%)
DIS   93.38 (+0.90%)
AMC   5.94 (-2.14%)
PYPL   73.57 (-0.88%)
PFE   51.72 (-0.12%)
NFLX   320.01 (+3.14%)
S&P 500   3,934.38 (-0.73%)
DOW   33,476.46 (-0.90%)
QQQ   282.04 (-0.64%)
AAPL   142.16 (-0.34%)
MSFT   245.42 (-0.80%)
META   115.90 (+0.49%)
GOOGL   92.83 (-0.94%)
AMZN   89.09 (-1.39%)
TSLA   179.05 (+3.23%)
NVDA   170.01 (-0.98%)
NIO   12.63 (-5.82%)
BABA   91.34 (-3.01%)
AMD   68.59 (-2.67%)
T   19.09 (-0.16%)
MU   54.87 (-0.60%)
CGC   2.87 (-7.12%)
F   13.18 (+0.46%)
GE   81.45 (-2.61%)
DIS   93.38 (+0.90%)
AMC   5.94 (-2.14%)
PYPL   73.57 (-0.88%)
PFE   51.72 (-0.12%)
NFLX   320.01 (+3.14%)
S&P 500   3,934.38 (-0.73%)
DOW   33,476.46 (-0.90%)
QQQ   282.04 (-0.64%)
AAPL   142.16 (-0.34%)
MSFT   245.42 (-0.80%)
META   115.90 (+0.49%)
GOOGL   92.83 (-0.94%)
AMZN   89.09 (-1.39%)
TSLA   179.05 (+3.23%)
NVDA   170.01 (-0.98%)
NIO   12.63 (-5.82%)
BABA   91.34 (-3.01%)
AMD   68.59 (-2.67%)
T   19.09 (-0.16%)
MU   54.87 (-0.60%)
CGC   2.87 (-7.12%)
F   13.18 (+0.46%)
GE   81.45 (-2.61%)
DIS   93.38 (+0.90%)
AMC   5.94 (-2.14%)
PYPL   73.57 (-0.88%)
PFE   51.72 (-0.12%)
NFLX   320.01 (+3.14%)
S&P 500   3,934.38 (-0.73%)
DOW   33,476.46 (-0.90%)
QQQ   282.04 (-0.64%)
AAPL   142.16 (-0.34%)
MSFT   245.42 (-0.80%)
META   115.90 (+0.49%)
GOOGL   92.83 (-0.94%)
AMZN   89.09 (-1.39%)
TSLA   179.05 (+3.23%)
NVDA   170.01 (-0.98%)
NIO   12.63 (-5.82%)
BABA   91.34 (-3.01%)
AMD   68.59 (-2.67%)
T   19.09 (-0.16%)
MU   54.87 (-0.60%)
CGC   2.87 (-7.12%)
F   13.18 (+0.46%)
GE   81.45 (-2.61%)
DIS   93.38 (+0.90%)
AMC   5.94 (-2.14%)
PYPL   73.57 (-0.88%)
PFE   51.72 (-0.12%)
NFLX   320.01 (+3.14%)
NYSE:STE

STERIS - STE Stock Forecast, Price & News

$191.96
+1.68 (+0.88%)
(As of 12/9/2022 12:00 AM ET)
Add
Compare
Today's Range
$188.99
▼
$192.43
50-Day Range
$160.98
▼
$192.31
52-Week Range
$159.21
▼
$255.93
Volume
834,677 shs
Average Volume
536,153 shs
Market Capitalization
$19.16 billion
P/E Ratio
N/A
Dividend Yield
0.99%
Price Target
$242.40

STERIS MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.80 Rating Score
Upside/​Downside
26.3% Upside
$242.40 Price Target
Short Interest
Healthy
1.85% of Float Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
-2.00
Upright™ Environmental Score
News Sentiment
0.38mentions of STERIS in the last 14 days
Based on 6 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
11.24%
From $8.45 to $9.40 Per Share

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.56 out of 5 stars

Medical Sector

115th out of 1,022 stocks

Surgical Appliances & Supplies Industry

8th out of 24 stocks

See Top Rated MarketRank™ Stocks Here
STE stock logo

About STERIS (NYSE:STE) Stock

STERIS plc provides infection prevention and other procedural products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and powered dental instruments, infection control products, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.

Receive STE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for STERIS and its competitors with MarketBeat's FREE daily newsletter.

STE Stock News Headlines

December 8, 2022 | americanbankingnews.com
STERIS plc (NYSE:STE) Receives $243.75 Consensus Price Target from Analysts
December 3, 2022 | americanbankingnews.com
STERIS (NYSE:STE) Downgraded by StockNews.com to "Hold"
November 17, 2022 | finance.yahoo.com
Why It Might Not Make Sense To Buy STERIS plc (NYSE:STE) For Its Upcoming Dividend
November 13, 2022 | finance.yahoo.com
STERIS Second Quarter 2023 Earnings: Misses Expectations
November 9, 2022 | finance.yahoo.com
STERIS Announces Financial Results for Fiscal 2023 Second Quarter
November 2, 2022 | finance.yahoo.com
STERIS Declares $0.47 per share Dividend
October 28, 2022 | nz.finance.yahoo.com
Surgical Drapes & Gowns Market Research Report by Type, Usage Pattern, End-User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19
October 26, 2022 | nz.finance.yahoo.com
Global Bio-Decontamination Market Report 2022: Featuring Ecolab, Fedegari Autoclavi, Steris, Tomi Environmental Solutions and JCE Biotechnology
October 26, 2022 | marketwatch.com
Washer-Disinfector-Dryers Market Size, Share 2023 Global Business Growth, Industry Revenue, Demand and Applications Market Research Report to 2028
October 26, 2022 | finance.yahoo.com
US Surface Disinfectants Market is estimated to be valued over USD 4.72 million by 2028 - Research by Exactitude Consultancy
October 25, 2022 | marketwatch.com
Surgical Lighting Systems Market Global Outlook, and Forecast 2022 To 2028.
October 25, 2022 | finance.yahoo.com
STERIS to Host a Conference Call for Fiscal 2023 Second Quarter Financial Results on November 10, 2022
October 18, 2022 | marketwatch.com
Veterinary Handheld Surgical Instrument Market 2022 Key Product Segments, Application Analysis, and Industry Growth Forecast by 2028
October 17, 2022 | nasdaq.com
3 Fast-Growing Medical Dividend Stocks - Nasdaq
October 8, 2022 | marketwatch.com
Rotatable Snare Market Size, Share and Forecast till 2028
October 8, 2022 | marketwatch.com
Surgical Tables Market Share, Size Global Growth Prospects, Growth, Trends, Industry Analysis, Key Players and Forecast to 2028
October 8, 2022 | nasdaq.com
Is There Now An Opportunity In STERIS plc (NYSE:STE)?
October 4, 2022 | bizjournals.com
Centerline Biomedical, the Cleveland medical technology developer, hires a new CEO - The Business Journals
October 2, 2022 | fool.com
Got $3,000? Here Are 2 Stocks That Will Make You Richer - The Motley Fool
September 29, 2022 | marketwatch.com
Cleanroom Goggles Market 2022 Latest Research, Top Impacting Factors, Growth Strategies and Forecast to 2028
September 29, 2022 | marketwatch.com
Endoscope Reprocessing Market 2022 : Share and Outlook of Regulatory Scenario by 2027 with Top Countries Data
September 28, 2022 | businesswire.com
United States Patient Positioning Systems Market Trends/Analysis Report 2022-2030 Featuring Medtronic, Stryker, Hill-Rom, SchureMed, Skytron, Smith & Nephew, STERIS, Leoni, Schaerer Medical, & Mizuho - ResearchAndMarkets.com - Business Wire
September 28, 2022 | marketwatch.com
Global Ward Washer Disinfectors Market Size 2022, Share, Analysis, Development, Revenue, Future Growth, Business Prospects and Forecast to 2028
September 26, 2022 | marketwatch.com
Cordless Headlights Market Size, Types, Applications, Top Manufacturers, Growth Techniques, Future Trends and Forecast to 2028
September 23, 2022 | benzinga.com
Needham Downgrades This Medical Equipment Stock Due To Lawsuit Risk - Steris (NYSE:STE) - Benzinga
See More Headlines
Receive STE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for STERIS and its competitors with MarketBeat's FREE daily newsletter.

STE Company Calendar

Ex-Dividend for 9/23 Dividend
9/06/2022
Dividend Payable
9/23/2022
Last Earnings
11/09/2022
Ex-Dividend for 12/16 Dividend
11/21/2022
Today
12/09/2022
Dividend Payable
12/16/2022
Next Earnings (Estimated)
2/14/2023
Fiscal Year End
3/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Surgical appliances & supplies
Sub-Industry
Health Care Equipment
Sector
Medical
Current Symbol
NYSE:STE
CUSIP
85915210
CIK
1624899
Web
www.steris.com
Phone
(531) 232-2000
Fax
440-639-4457
Employees
16,422
Year Founded
1987

Price Target and Rating

Average Stock Price Forecast
$242.40
High Stock Price Forecast
$275.00
Low Stock Price Forecast
$210.00
Forecasted Upside/Downside
+26.3%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.80
Research Coverage
5 Analysts

Profitability

EPS (Most Recent Fiscal Year)
($0.11)
Trailing P/E Ratio
N/A
Forward P/E Ratio
22.72
P/E Growth
2
Net Income
$243.89 million
Net Margins
-0.17%
Pretax Margin
1.17%
Return on Equity
12.75%
Return on Assets
7.23%

Debt

Debt-to-Equity Ratio
0.49
Current Ratio
2.16
Quick Ratio
1.42

Sales & Book Value

Annual Sales
$4.59 billion
Price / Sales
4.18
Cash Flow
$14.45 per share
Price / Cash Flow
13.28
Book Value
$65.36 per share
Price / Book
2.94

Miscellaneous

Outstanding Shares
99,823,000
Free Float
98,875,000
Market Cap
$19.16 billion
Optionable
Optionable
Beta
0.82

Social Links


Key Executives

  • Mr. Daniel A. CarestioMr. Daniel A. Carestio (Age 49)
    Pres, CEO & Director
    Comp: $1.63M
  • Mr. Michael J. TokichMr. Michael J. Tokich (Age 53)
    Sr. VP & CFO
    Comp: $1.03M
  • Mr. John Adam ZangerleMr. John Adam Zangerle (Age 55)
    Sr. VP, Gen. Counsel & Sec.
    Comp: $800.03k
  • Mr. Walter M. Rosebrough Jr.Mr. Walter M. Rosebrough Jr. (Age 68)
    CEO Emeritus & Sr. Advisor
    Comp: $1.16M
  • Mr. Cary L. Majors (Age 47)
    Sr. VP of Americas Commercial Operations
    Comp: $734.37k
  • Mr. Andrew Xilas (Age 57)
    Sr. VP & GM of Dental
    Comp: $1.44M
  • Ms. Karen L. BurtonMs. Karen L. Burton (Age 54)
    Chief Accounting Officer, VP & Controller
  • Julie Winter
    VP of Investor Relations & Corp. Communications
  • Ms. Mary Clare Fraser (Age 52)
    VP & Chief HR Officer
  • Ms. Julia K. Madsen (Age 57)
    Sr. VP of Life Sciences

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions













STE Stock - Frequently Asked Questions

Should I buy or sell STERIS stock right now?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for STERIS in the last year. There are currently 1 hold rating and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" STE shares.
View STE analyst ratings or view top-rated stocks.

What is STERIS's stock price forecast for 2023?

5 equities research analysts have issued twelve-month target prices for STERIS's stock. Their STE share price forecasts range from $210.00 to $275.00. On average, they predict the company's stock price to reach $242.40 in the next twelve months. This suggests a possible upside of 26.3% from the stock's current price.
View analysts price targets for STE or view top-rated stocks among Wall Street analysts.

How have STE shares performed in 2022?

STERIS's stock was trading at $243.41 at the beginning of 2022. Since then, STE stock has decreased by 21.1% and is now trading at $191.96.
View the best growth stocks for 2022 here.

When is STERIS's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 14th 2023.
View our STE earnings forecast.

How were STERIS's earnings last quarter?

STERIS plc (NYSE:STE) issued its quarterly earnings results on Wednesday, November, 9th. The medical equipment provider reported $1.99 earnings per share for the quarter, topping analysts' consensus estimates of $1.98 by $0.01. The medical equipment provider had revenue of $1.20 billion for the quarter, compared to analyst estimates of $1.22 billion. STERIS had a positive trailing twelve-month return on equity of 12.75% and a negative net margin of 0.17%. The company's quarterly revenue was up .3% on a year-over-year basis. During the same quarter last year, the company posted $1.99 earnings per share.
Read the conference call transcript.

How often does STERIS pay dividends? What is the dividend yield for STERIS?

STERIS announced a quarterly dividend on Wednesday, November 2nd. Stockholders of record on Tuesday, November 22nd will be given a dividend of $0.47 per share on Friday, December 16th. This represents a $1.88 annualized dividend and a dividend yield of 0.98%. The ex-dividend date is Monday, November 21st.
Read our dividend analysis for STE.

Is STERIS a good dividend stock?

STERIS (NYSE:STE) pays an annual dividend of $1.88 per share and currently has a dividend yield of 0.99%.
Read our dividend analysis for STE.

What guidance has STERIS issued on next quarter's earnings?

STERIS issued an update on its FY 2023 earnings guidance on Friday, December, 9th. The company provided EPS guidance of $8.40-$8.60 for the period, compared to the consensus earnings per share estimate of $8.49. The company issued revenue guidance of $4.95 billion-$4.95 billion, compared to the consensus revenue estimate of $4.98 billion.

What is Walter M. Rosebrough, Jr.'s approval rating as STERIS's CEO?

196 employees have rated STERIS Chief Executive Officer Walter M. Rosebrough, Jr. on Glassdoor.com. Walter M. Rosebrough, Jr. has an approval rating of 79% among the company's employees.

What other stocks do shareholders of STERIS own?

Based on aggregate information from My MarketBeat watchlists, some companies that other STERIS investors own include Johnson & Johnson (JNJ), Home Depot (HD), AT&T (T), Visa (V), AbbVie (ABBV), Abbott Laboratories (ABT), Pfizer (PFE), Gilead Sciences (GILD), Mastercard (MA) and Medtronic (MDT).

What is STERIS's stock symbol?

STERIS trades on the New York Stock Exchange (NYSE) under the ticker symbol "STE."

Who are STERIS's major shareholders?

STERIS's stock is owned by many different retail and institutional investors. Top institutional investors include Vanguard Group Inc. (11.86%), BlackRock Inc. (8.03%), WCM Investment Management LLC (5.79%), Massachusetts Financial Services Co. MA (5.09%), State Street Corp (4.30%) and Price T Rowe Associates Inc. MD (2.26%). Insiders that own company stock include Cary L Majors, Cary L Majors, Cynthia L Feldmann, Daniel A Carestio, David B Lewis, Jacqueline B Kosecoff, John Adam Zangerle, Julia Madsen, Karen L Burton, Michael J Tokich, Mohsen Sohi, Renato Tamaro, Richard C Breeden and Walter M Rosebrough Jr.
View institutional ownership trends.

How do I buy shares of STERIS?

Shares of STE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is STERIS's stock price today?

One share of STE stock can currently be purchased for approximately $191.96.

How much money does STERIS make?

STERIS (NYSE:STE) has a market capitalization of $19.16 billion and generates $4.59 billion in revenue each year. The medical equipment provider earns $243.89 million in net income (profit) each year or ($0.11) on an earnings per share basis.

How many employees does STERIS have?

The company employs 16,422 workers across the globe.

How can I contact STERIS?

STERIS's mailing address is 70 Sir John Rogerson`s Quay, Dublin L2, D02 R296. The official website for the company is www.steris.com. The medical equipment provider can be reached via phone at (531) 232-2000, via email at julie_winter@steris.com, or via fax at 440-639-4457.

This page (NYSE:STE) was last updated on 12/9/2022 by MarketBeat.com Staff